Clinical trial
A Multi-Center, Randomized, Double-Blind, Parallel-Group, Multiple-Dose, Adaptive Study Assessing the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of TTP399 in With Adult Patients Type 1 Diabetes Mellitus
NCT03335371 is registered in ClinicalTrials.gov with vTv Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Double-Blind, Parallel-Group, Multiple-Dose, Adaptive Study Assessing the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of TTP399 in With Adult Patients Type 1 Diabetes Mellitus
- Lead sponsor
- vTv Therapeutics
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 25, 2017
- Completion date
- January 6, 2020
- Enrollment
- 115 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.